SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 40.47 |
Enterprise Value ($M) | 82.95 |
Book Value ($M) | 17.28 |
Book Value / Share | 0.77 |
Price / Book | 2.34 |
NCAV ($M) | -97.06 |
NCAV / Share | -4.32 |
Price / NCAV | -0.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.41 |
Return on Assets (ROA) | -0.24 |
Return on Equity (ROE) | -0.86 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.14 |
Current Ratio | 0.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 14.50 |
Assets | 128.84 |
Liabilities | 111.56 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Bristol Myers Squibb Co | |||
13D/A | Dragasac Ltd | |||
13G/A | UNITED THERAPEUTICS Corp | 4.11 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
99,875 | 213,401 | 46.80 | |
90,625 | 152,560 | 59.40 | |
40,141 | 125,029 | 32.11 | |
43,175 | 129,617 | 33.31 | |
(click for more detail) |
Similar Companies | |
---|---|
CDIO – Cardio Diagnostics Holdings, Inc. | CDTX – Cidara Therapeutics, Inc. |
CDXC – ChromaDex Corporation | CELZ – Creative Medical Technology Holdings, Inc. |
CGEN – Compugen Ltd. |
Financial data and stock pages provided by
Fintel.io